Inovio Pharma (INO) Swings to Q3 Profit
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.12 --0%
EPS Growth %: +60.7%
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +60.7%
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q3 EPS of $0.07, versus ($0.12) reported last year. Revenue for the quarter came in at $24.18 million, versus $1.84 million reported last year.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- Hermès can regain momentum despite China weakness, Jefferies says
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
